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INTRODUCTION
Amphetamine (AMP) and Methamphetamine (MET) are potent CNS stimulants which also produce anorectic and sympathomimetic actions [1] . Both substances belong to phenethylamine family (and more specifically, its phenylisopropylamine branch) of nitrogen-containing drugs ( Fig. 1) , chemically related to the naturally occurring trace amine neuromodulators, namely phenethylamine itself and N-methylphenethylamine. Although some of amphetamine's substituted derivatives occur in nature [2] , usually amphetamines are synthetically produced. According to the official United Nations Office on Drugs and Crime (UNODC) statistic report [3] , amphetamines are the second most popular drugs next to cannabis; there were more than 35 million people affected worldwide as of 2016 (ecstasy excluded). For the same period, amphetamines users in Europe were estimated to 2.4 million (0.4% of the population) [ibid.].
Amphetamines are illegal drugs in most countries and their detection is an often task in analytical toxicology. In Bulgaria amphetamine compounds fall under Group I of controlled substances -"Substances of high risk prohibited for medical use"). Pharmacokinetic properties include biological half-live of 6-15 h for MET and 4-8 h for AMP [4] . However, AMP is almost always present in cases of MET intoxication as it is one of its major metabolites. Low effective concentrations in body fluids and moderate biological half-life make detection of amphetamines in urine and blood samples usually possible within some 24 hours after intoxication, although a high dose may be detectable for up to several days [5] .
Preliminary detection methods are mostly based on immunoassay; they give express results (usually in the order of minutes) and feature good cut-off concentration levels. For example, Dräger DrugCheck ® 3000 routinely used by Bulgarian traffic police features a cut-off level of 50 ng/ mL for amphetamines in oral fluid [6] . However, due to low analytical specificity and non-zero risk of false positive/ false negative results, a confirmative method for analysis is mandatory in most cases. As a gold standard for this purpose, a gas chromatography mass-spectrometry technique is widely accepted and reviewed [7] [8] [9] [10] [11] . Some of the GS-MS methods achieve excellent results, although the rush for sensitivity complicates the procedure and increases the lab time. Indeed, there are simplified techniques, but purification of the sample is sacrificed along the way. Therefore, researching the most efficient approach by combining the advantages of already known studies and optimising the procedure is the main task of the study.
MATERIALS AND METHODS
Analytical grade or better chemical reagents were used. Preparation of the necessary solutions involves only https://doi.org/10.5272/jimab.2017232.1603 HPLC grade solvents and purified deionized water (0.067-0.100 ìS cm -1 , TKA™ Pacific water purification system). Certified reference material (Quick-Check™ Drug Solutions of 1 mg mL -1 AMP in MeOH and 1 mg mL -1 MET in MeOH) were purchased from Alltech Associates, Inc., USA. SPE Phenomenex ® cartridges (Strata ® Screen-C, 55ìm, 70Å, 150 mg/3mL tubes) were used. Pentafluoropropionic anhydride (for GC derivatization, 99%) was purchased from Sigma-Aldrich Co. LLC. Random samples of human blood and plasma from controlled stationary patients of Naval Hospital -Varna, available at Clinical Laboratory, were used for preparation of spiked samples.
GC-MS analysis was done on Agilent Technologies 7890B GC System & 5977A MSD module. Data acquisition and processing were controlled by Agilent MassHunter software package. Reference data from mass spectral library NIST version 2.0 g was used for comparison.
Statistical analysis was done using the OriginPro ® software.
RESULTS AND DISCUSSION
Reference data Before analysis of biological matrices, appropriately diluted standard AMP and MET solutions were used to record reference GC-MS data. Analysis conditions are listed in Table 1 . As it has been proven inconvenient to switch software settings over and over again in state of emergency, all GC-MS parameters have been intentionally left unoptimized to match the screening procedure used on daily basis. 
Experimental procedure
Purification of biological matrices before GC-MS analysis was done by mean of solid-phase extraction using silica-based strong type cation exchanger. The procedure is very close to already published technique for cocaine determination [13]:
(1) Condition the SPE column applying 2 mL MeOH followed by 2 mL water.
(2) Prepare the sample by diluting 1 mL blood serum/plasma with 2 mL of water, or by diluting 1 mL urine with 2 mL of 0.1 M phosphate buffer pH 6.0. Load the sample at rate as low as 1 drop per second.
(3) Wash the column consequently by 2 mL 0.1 M HCl and 2 mL MeOH.
(4) Dry at full vacuum for 2 minutes.
(5) Elute drop wise using 2 mL 5% ammonium hydroxide in MeOH.
(6) Thoroughly evaporate under nitrogen stream (at < 60 o C) to complete dryness. 
Method validation
There are increased demands on results' accuracy and precision because method is usually used as confirmative instrument in medico legal practice. We used fortified acceptance criteria before declaring any sample positive. Unusually severe set of requirements are a priori constructed and strictly followed during both validation and working cycles. Simultaneous agreement is required on all next subjects:
(1) Sample signal Rt within 1% of calibration value and better than 20% qualifying ions ratios agreement;
(2) All qualifying ion maximum intensities obey three-sigma rule toward the background noise (p < 0.01); (3) Software identification agreement according to NIST database.
The strongly recommended empirical approach [14, 15] is represented by set (1). Statistical approach is represented by set (2) . In attempt to reduce as much as possible type I (false positive) errors, we apply all sets cited.
LoD determination was done by menas of spiked blood samples (at levels 500, 400, 300, 200, 100, 50, 25, 10 ng mL -1 ) for both substance of interest. LoD was associated with the lowest analyte concentration at which all of the acceptance criteria are still agreed. For AMP LoD was estimated to 25 ng mL -1 , and for MET -to 10 ng mL -1 .
Due to the severe requirements accepted, presence of amphetamines in test samples even at LoD levels was proven to produce clear visible evidence of well-defined peak area, as it is shown on Fig. 2 for example. 
CONCLUSION
Available methods for amphetamines identification in biological matrices have been critically considered. An optimized approach, best fitted to given laboratory equipment has been proposed. Certified analytical standards have been used in method validation. It has been demonstrated that procedure gives accurate and precise results. Optimized method is robust, simple and relatively short (under 2 hours). Limits of detection are proven better than of immunoassay methods routinely used by traffic police, however running GC-MS in SIM mode could be a handy solution if yet better sensitivity is required. Starting the procedure with larger samples (e.g. 2 ml blood or more, if available) is another option of the same effect.
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